Zymeworks Inc. Common Stock (ZYME) — Free Cash Flow Generation Index
Zymeworks Inc. Common Stock (ZYME) has a Free Cash Flow Generation Index of 0.93x as of June 2025. Free cash flow of $11.19 Million represents 1% of operating cash flow ($12.07 Million). Explore reinvestment intensity of Zymeworks Inc. Common Stock to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zymeworks Inc. Common Stock Free Cash Flow Generation Index (2017–2022)
Historical FCF Generation Index trend for Zymeworks Inc. Common Stock across 3 annual periods. For the full cash flow conversion analysis, see ZYME cash flow conversion.
Annual Free Cash Flow Generation for Zymeworks Inc. Common Stock (2017–2022)
Year-by-year Free Cash Flow Generation Index for Zymeworks Inc. Common Stock. Check how aggressively does Zymeworks Inc. Common Stock reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.91x | $130.98 Million | $144.11 Million | $13.12 Million | ▲ +5.9% |
| 2018 | 0.86x | $20.76 Million | $24.18 Million | $3.42 Million | ▲ +106.5% |
| 2017 | -13.25x | $-2.90 Million | $219.00K | $3.12 Million | — |